Mattia Galli: Sex-related Differences in Platelet Reactivity in Patients Both On and Off Antiplatelet Therapy
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared a proud post on LinkedIn:
”Sex-related differences in platelet reactivity are emerging as a relevant factor in patients both on and off antiplatelet therapy.
In these two recent contributions, published almost simultaneously, we present evidence from both randomized controlled trials and the largest pharmacodynamic study in this setting to date, suggesting that females may benefit from antiplatelet regimens different from those typically used in males.
This represents another important step forward in advancing precision medicine in cardiology.”
Read the full articles in European Heart Journal and EHJ Cardiovascular Pharmacotherapy.
Article 1: Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Authors: Giovanni Occhipinti , Claudio Laudani , Mattia Galli , Luis Ortega-Paz , Vijay Kunadian , Guiomar Mendieta , Riccardo Rinaldi , Felicita Andreotti , Roxana Mehran , Teresa López-Sobrino , Davide Capodanno , Dominick J Angiolillo , Manel Sabaté Tenas , Salvatore Brugaletta
Article 2: Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy
Authors: Mattia Galli , Sergio Terracina , Eleonora Schiera , Simone De Corci , Diego Sangiorgi , Massimo Mancone , Luigi Frati , Sebastiano Sciarretta , Dominick J Angiolillo , Fabio M Pulcinelli
Stay updated on all science in the field of platelet disorders with Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants